A pooled analysis comparing the outcomes of elderly to younger patients on nctn trials of concurrent ccrt for stage 3 NSCLC

Document Type

Conference Proceeding

Publication Date

1-2017

Publication Title

J Thorac Oncol

Abstract

Background: Concurrent chemoradiotherapy (CCRT) is the standard treatment (TRT) for stage 3 NSCLC. Elderly patients (pts) are common, may have increased toxicity,& poorer results from CCRT. Methods: Individual patient data (IPD) from NCTN phase 2/3 trials of CCRT for stage 3 NSCLC from 1990- 2012 was collected. We compared the overall survival (OS), progression-free survival (PFS), & adverse events (AE's) for pts age ≥70 years (yrs) (elderly) vs.(younger). Unadjusted & adjusted Hazard Ratios (HRs) for survival time & their confidence intervals (CIs) were estimated by single-predictor & multivariable Cox models. Unadjusted & adjusted Odds Ratio (OR) for AE's & their CIs were obtained from single-predictor & multivariable logistic regression models. Results: IPD from 16 trials were analyzed; 2,768 pts were younger & 832 were elderly. Median OS & PFS for elderly & younger pts are in the table. In the unadjusted & multivariable models elderly pts had worse OS (HR=1.23; 95%CI =1.13-1.35, and 1.20; 95%CI=1.10-1.32, respectively). In the unadjusted & multivariable models, elderly & younger pts had a similar PFS (HR=1.02; 95% CI=0.94-1.11 and 1.01, 95% CI=0.92-1.10, respectively). Elderly pts had a higher rate of grade ≥3 AE's in the unadjusted & multivariable models (OR=1.25; 95% CI=1.00-1.57 and 1.30; 95%CI=1.03-1.62, respectively). A lower percentage of elderly pts compared to younger completed TRT (47% and 57%, respectively; P

Volume

12

Issue

1

First Page

S374

Last Page

S375

This document is currently not available here.

Share

COinS